Company Name: Retrophin, Inc.
Retrophin, Inc. is a biopharmaceutical company. The company is engaged in developing, acquiring and commercializing treatments for catastrophic, rare or serious diseases. The company’s marketed products and developmental pipeline include:
- Chenodal: Marketed treatment for gallstones
- Thiola: Marketed treatment for cystinuria
- Cholbam: Marketed treatment for bile acid synthesis disorders (due to single enzyme defects) and peroxisomal disorders
- Developmental pipeline: Includes product candidates for focal segmental glomerulosclerosis (FSGS) and pantothenate kinase-associated neurodegeneration (PKAN)
Ticker Symbol: RTRX (NASDAQ)
Company Website: www.retrophin.com
Social Media:
Headquarters: San Diego, CA